Angiotensin-Converting Enzyme InhibitorsEnalaprilCaptoprilLisinoprilAngiotensin Receptor AntagonistsPerindoprilEnalaprilatAntihypertensive AgentsRamiprilCilazaprilAngiotensin II Type 1 Receptor BlockersEnzyme InhibitorsHypertensionRenin-Angiotensin SystemTeprotideBlood PressureThiazepinesReninTetrazolesDiureticsAdrenergic beta-AntagonistsImidazolidinesAngioedemaTetrahydroisoquinolinesLosartanAngiotensin IIBradykinin3-Mercaptopropionic AcidHeart FailurePeptidyl-Dipeptidase ADrug Therapy, CombinationKininsProteinuriaAngiotensin IBiphenyl CompoundsFosinoprilAbstracting and Indexing as TopicRats, Inbred SHRSaralasinKidneyCalcium Channel BlockersReceptors, BradykininTime FactorsHyperkalemiaAngiotensinsImidazolesTreatment OutcomeAldosteroneBenzimidazolesHydrochlorothiazideDose-Response Relationship, DrugSodium Chloride Symporter InhibitorsHydralazineCardiovascular AgentsHemodynamicsHypertension, RenalRats, Inbred WKYIndolesReceptor, Angiotensin, Type 1Double-Blind MethodReceptors, AngiotensinBenzazepinesCongresses as TopicDiabetic NephropathiesKidney DiseasesRats, Inbred StrainsKidney Failure, ChronicMineralocorticoid Receptor AntagonistsHypertension, RenovascularProlineAmlodipineRandomized Controlled Trials as TopicGlomerular Filtration RateSpironolactoneDipeptidesHeart RateMopidamolCreatinineDogsAlbuminuriaReceptor, Bradykinin B2Myocardial InfarctionHydroxymethylglutaryl-CoA Reductase InhibitorsRenal CirculationRats, WistarRats, Sprague-DawleyValineCardiac Output, LowOligopeptidesProtease InhibitorsIsoquinolinesOligohydramniosOrgan SizeRetrospective StudiesCoughFumaratesRisk FactorsVentricular Dysfunction, LeftNephrectomyFollow-Up Studies